Systemic immune–inflammation index as a useful prognostic indicator predicts survival in patients with advanced gastric cancer treated with neoadjuvant chemotherapy

References

• SiegelRLMillerKDJemalACancer Statistics, 2015CA Cancer J Clin201565152925559415
   PubMed Web of Science ®Google Scholar
• DeSantisCELinCCMariottoABCancer treatment and survivorship statistics, 2014CA Cancer J Clin201464425227124890451
   PubMed Web of Science ®Google Scholar
• FockKMReview article: the epidemiology and prevention of gastric cancerAliment Pharmacol Ther201440325026024912650
   PubMed Web of Science ®Google Scholar
• FerroAPeleteiroBMalvezziMWorldwide trends in gastric cancer mortality (1980–2011), with predictions to 2015, and incidence by subtypeEur J Cancer20145071330134424650579
   PubMed Web of Science ®Google Scholar
• MackenzieMSpithoffKJonkerDSystemic therapy for advanced gastric cancer: a clinical practice guidelineCurr Oncol2011184e202e20921874111
   PubMed Web of Science ®Google Scholar
• BiondiALirosiMCD’UgoDNeo-adjuvant chemo(radio) therapy in gastric cancer: current status and future perspectivesWorld J Gastrointest Oncol201571238940026690252
   PubMed Web of Science ®Google Scholar
• ManoharanVLeeSChongSSerial imaging using [18F] Fluorodeoxyglucose positron emission tomography and histopathologic assessment in predicting survival in a population of surgically resectable distal oesophageal and gastric adenocarcinoma following neoadjuvant therapyAnn Nucl Med201731431532328299585
   PubMed Web of Science ®Google Scholar
• MingolFGallegoJOrduñaATumor regression and survival after perioperative MAGIC-style chemotherapy in carcinoma of the stomach and gastroesophageal junctionBMC Surg2015156625997454
   PubMed Web of Science ®Google Scholar
• Neves FilhoEHde Sant’AnaRONunesLVPiresAPda CunhaMDHistopathological regression of gastric adenocarcinoma after neoadjuvant therapy: a critical reviewAPMIS20171252798428044374
   PubMed Web of Science ®Google Scholar
• ParkSCChunHJChemotherapy for advanced gastric cancer: review and update of current practicesGut Liver20137438539323898376
   PubMed Web of Science ®Google Scholar
• el AzizLMBlood neutrophil-lymphocyte ratio predicts survival in locally advanced cancer stomach treated with neoadjuvant chemotherapy FOLFOX4Med Oncol2014311231125367855
   PubMed Web of Science ®Google Scholar
• KimKHKwonHCOhSYClinicopathological significance of ERCC1, thymidylate synthase and glutathione S-transferase P1 expression for advanced gastric cancer patients receiving adjuvant 5-Fu and cisplatin chemotherapyBiomarkers2011161748221133646
   PubMed Web of Science ®Google Scholar
• LimHMoonAInflammatory fibroblasts in cancerArch Pharm Res20163981021103127384063
   PubMed Web of Science ®Google Scholar
• ElinavENowarskiRThaissCAHuBJinCFlavellRAInflammation-induced cancer: crosstalk between tumors, immune cells and microorganismsNat Rev Cancer2013131175977124154716
   PubMed Web of Science ®Google Scholar
• DiakosCICharlesKAMcMillanDCClarkeSJCancer-related inflammation and treatment effectivenessLancet Oncol20141511e493e50325281468
   PubMed Web of Science ®Google Scholar
• BorsigLWolfMJRoblekMLorentzenAHeikenwalderMInflammatory chemokines and metastasis-tracing the accessoryOncogene201433253217322423851506
   PubMed Web of Science ®Google Scholar
• LolliCCaffoOScarpiESystemic immune-inflammation index predicts the clinical outcome in patients with mCRPC treated with AbirateroneFront Pharmacol2016737627790145
   PubMed Web of Science ®Google Scholar
• LolliCBassoUDerosaLSystemic immune inflammation index predicts the clinical outcome in patients with metastatic renal cell cancer treated with sunitinibOncotarget2016734545645457127409344
   PubMedGoogle Scholar
• WangLWangCWangJHuangXChengYA novel systemic immune-inflammation index predicts survival and quality of life of patients after curative resection for esophageal squamous cell carcinomaJ Cancer Res Clin Oncol2017143102077208628601935
   PubMed Web of Science ®Google Scholar
• AminMBAminMBGreeneFLThe eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more “personalized” approach to cancer stagingCA Cancer J Clin2017672939928094848
   PubMed Web of Science ®Google Scholar
• LaurenPThe two histological main types of gastric carcinoma: diffuse and so-called intestinaltype carcinoma. An attempt at a histo-clinical classificationActa Pathol Microbiol Scand196564314914320675
   PubMedGoogle Scholar
• Cancer Genome Atlas Research NetworkComprehensive molecular characterization of gastric adenocarcinomaNature20145137517s202s209
   PubMed Web of Science ®Google Scholar
• EisenhauerEATherassePBogaertsJNew response evaluation criteria in solid tumors: revised RESIST guideline (version 1.1)Eur J Cancer200945222824719097774
   PubMed Web of Science ®Google Scholar
• CaussanelJPLéviFBrienzaSPhase I trial of 5-day continuous venous infusion of oxaliplatin at circadian rhythmmodulated rate compared with constant rateJ Natl Cancer Inst19908212104610502348469
   PubMed Web of Science ®Google Scholar
• QuéroLaurentGuillermSophieHennequinChristopheNeoadjuvant or adjuvant therapy for gastric cancerWorld J Gastrointest Oncol20157810211026306142
   PubMed Web of Science ®Google Scholar
• SoerjomataramILortet-TieulentJParkinDMGlobal burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regionsLancet201238098561840185023079588
   PubMed Web of Science ®Google Scholar
• MantovaniAAllavenaPSicaABalkwillFCancer-related inflammationNature2008454720343644418650914
   PubMed Web of Science ®Google Scholar
• McMillanDCSystemic inflammation, nutritional status and survival in patients with cancerCurr Opin Clin Nutr Metab Care200912322322619318937
   PubMed Web of Science ®Google Scholar
• LiTJJiangYMHuYFInterleukin-17-producing neutrophils link inflammation stimuli to disease progression by promoting angiogenesis in gastric cancerClin Cancer Res20172361575158527620275
   PubMed Web of Science ®Google Scholar
• EoWKJeongDWChangHJAbsolute monocyte and lymphocyte count prognostic score for patients with gastric cancerWorld J Gastroenterol20152192668267625759535
   PubMed Web of Science ®Google Scholar
• KılınçalpSEkizFBaşarOMean platelet volume could be possible biomarker in early diagnosis and monitoring of gastric cancerPlatelets201425859259423537073
   PubMed Web of Science ®Google Scholar
• QuigleyDAKristensenVPredicting prognosis and therapeutic response from interactions between lymphocytes and tumor cellsMol Oncol20159102054206226607741
   PubMed Web of Science ®Google Scholar
• OckCYNamARLeeJPrognostic implication of antitumor immunity measured by the neutrophil-lymphocyte ratio and serum cytokines and angiogenic factors in gastric cancerGastric Cancer201720225426227147244
   PubMed Web of Science ®Google Scholar
• ChenLHaoYZhuLHMonocyte to lymphocyte ratio predicts survival in patients with advanced gastric cancer undergoing neoadjuvant chemotherapyOnco Targets Ther2017104007401628860808
   PubMed Web of Science ®Google Scholar
• KohCHBhoo-PathyNNgKLUtility of pre-treatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as prognostic factors in breast cancerBr J Cancer2015113115015826022929
   PubMed Web of Science ®Google Scholar
• FengJFChenSYangXSystemic immune-inflammation index (SII) is a useful prognostic indicator for patients with squamous cell carcinoma of the esophagusMedicine (Baltimore)2017964e588628121932
   PubMed Web of Science ®Google Scholar
• KolaczkowskaEKubesPNeutrophil recruitment and function in health and inflammationNat Rev Immunol201313315917523435331
   PubMed Web of Science ®Google Scholar
• TanKWChongSZWongFHNeutrophils contribute to inflammatory lymphangiogenesis by increasing VEGF-A bioavailability and secreting VEGF-DBlood2013122223666367724113869
   PubMed Web of Science ®Google Scholar
• BauschDPauschTKraussTNeutrophil granulocyte derived MMP-9 is a VEGF independent functional component of the angiogenic switch in pancreatic ductal adenocarcinomaAngiogenesis201114323524321442180
   PubMed Web of Science ®Google Scholar
• JenneCNUrrutiaRKubesPPlatelets: bridging hemostasis, inflammation, and immunityInt J Lab Hematol201335325426123590652
   PubMed Web of Science ®Google Scholar
• LabelleMBegumSHynesROPlatelets guide the formation of early metastatic nichesProc Natl Acad Sci USA201411130E3053E306125024172
   PubMed Web of Science ®Google Scholar
• BambaceNMHolmesCEThe platelet contribution to cancer progressionJ Thromb Haemost20119223724921040448
   PubMed Web of Science ®Google Scholar
• BenoyISalgadoRColpaertCWeytjensRVermeulenPBDirixLYSerum interleukin 6, plasma VEGF, serum VEGF, and VEGF platelet load in breast cancer patientsClin Breast Cancer20022431131511899364
   PubMedGoogle Scholar
• FerroneCDranoffGDual roles for immunity in gastrointestinal cancersJ Clin Oncol201028264045405120644090
   PubMed Web of Science ®Google Scholar
• FondevilaCMetgesJPFusterJp53 and VEGF expression are independent predictors of tumor recurrence and survival following curative resection of gastric cancerBr J Cancer200490120621514710231
   PubMed Web of Science ®Google Scholar
• OgiyaRNiikuraNKumakiNComparison of tumor-infiltrating lymphocytes between primary and metastatic tumors in breast cancer patientsCancer Sci2016107121730173527727484
   PubMed Web of Science ®Google Scholar
• MilneKAlexanderCWebbJRAbsolute lymphocyte count is associated with survival in ovarian cancer independent of tumor-infiltrating lymphocytesJ Transl Med201210s33
   PubMed Web of Science ®Google Scholar